FARAHANI, P. NON-SEVERE HYPOGLYCEMIA RISK DIFFERENCE BETWEEN SULFONYLUREA AND SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS (SGLT2-I) AS AN ADD-ON TO METFORMIN IN RANDOMIZED CONTROLLED TRIALS. Journal of Population Therapeutics and Clinical Pharmacology, [S. l.], v. 24, n. 2, p. e32-e40, 2017. DOI: 10.22374/1710-6222.24.2.6. Disponível em: https://jptcp.com/index.php/jptcp/article/view/11. Acesso em: 16 jul. 2024.